Xylazin – alt und bewährt oder gefährlich und verbannt?

• Literatur

• 1 Ansah OB, Raekallio M, Vainio O. Correlation between serum concentrations following continuous intravenous infusion of dexmedetomidine or medetomidine in cats and their sedative and analgesic effects. J Vet Pharmacol Ther 2000; 23: 1-8.
• 2 Ansah OB. Use of the alpha-2-adrenoceptor agonists medetomidine and dexmedetomidine in the sedation and analgesia of domestic cats. Diss med vet Helsinki, Finnland: 2004
• 3 Bayer AG. http://www.pharma-und-chemiepark.de/downloads/pdf_meilensteine.pdf (letzter Zugriff 18.08.2009)
• 4 Becker K. Eine antagonisierbare Sedation mit Medetomidin, l-Methadon und Diazepam vor der Epiduralanästhesie beim Hund. Diss med vet Justus-Liebig-Universität Gießen; 1995
• 5 Belda E, Laredo FG, Escobar M, Soler M, Lucas X, Agut A. Sedative and cardiorespiratory effects of three doses of romifidine in comparison with medetomidine in five cats. Vet Rec 2008; 162 (03) 82-87.
• 6 Clarke KW, England GCW. Medetomidine, a new sedative-analgesic for use in the dog and its reversal with atipamezole. J Small Anim Pract 1989; 30: 343-348.
• 7 Clineschmidt BV, Pettibone DJ, Lotti VJ, Hucker HB, Sweeney BM, Reiss DR, Lis EV, Huff JR, Vacca J. A Peripherally Acting Alpha-2 Adrenoceptro Antagonist: L-659,066. J Pharmcol Exp Ther 1988; 245: 32-40.
• 8 ClinPharm. http://www.vetpharm.uzh.ch/wir/00000736/1617__F.htm (letzter Zugriff 19.08.2009)
• 9 England GCW, Clarke KW, Goosens L. A comparison of the sedative effects of three a-2 adrenoceptor agonists (romifidine, detomdine and xylazine) in the horse. J Vet Pharmacol Therapeut 1992; 15: 194-201
• 10 Enouri SS, Kerr CL, McDonell WN, O’Sullivan ML, Neto FJ. Effects of a peripheral alpha2 adrenergic-receptor antagonist on the hemodynamic changes induced by medetomidine administration in conscious dogs. Am J Vet Res 2008; 69: 728-736.
• 11 European Medicines Agency (EMEA). http://www.emea.europa.eu/vetdocs/PDFs/EPAR/dexdomitor/077202de1.pdf und http://www.emea.europa.eu/vetdocs/PDFs/EPAR/dexdomitor/077202en6.pdf (letzter Zugriff 19.08.2009)
• 12 Hall LW, Clarke KW, Trim CM. Principles of sedation, analgesia and premedication. In: Veterinary Anaesthesia. Hall LW, Clarke KW, Trim CM. eds. London: Saunders; 2001: 75-112.
• 13 Hamilton CA. The role of imidazoline receptors in blood pressure regulation. Pharmacol Ther 1992; 54: 231-248.
• 14 Hikasa Y, Ogasawara S, Takase K. Alpha adrenoceptor subtypes involved in the emetic action in dogs. J Pharmacol Exp Ther 1992; 261: 746-754.
• 15 Honkavaara JM, Raekallio MR, Kuusela EK, Hyvärinen EA, Vainio OM. The effects of L-659,066, a peripheral alpha2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs. Vet Anaesth Analg 2008; 35: 409-413.
• 16 Hsu WH. Xyalzine-induced depression and its antagonism by alpha-adrenergic blocking agents. J Pharmacol Exp Ther 1981; 218: 188-192.
• 17 Jarvis N, England GCW. Reversal of xylazine sedation in dogs. Vet Rec 1991; 128 (14) 323-325.
• 18 Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia 1999; 54: 146-165.
• 19 Kramer S, Schanen H, Hart S. Nolte Zur Antagonisierung von Xylazin/ l-Methadon und Medetomidin/l-Methadon durch Atipamezol und Naloxon beim Hund. Kleintierprax 1995; 40: 181-192.
• 20 Kuusela E, Raekallio M, Anttila M, Falck I, Molsa S, Vainio O. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J Vet Pharmacol Ther 2000; 23: 15-20.
• 21 Löscher W. Pharmaka mit Wirkung auf das Zentralnervensystem. In: Löscher W, Ungemach FR, Kroker R. Hrsg. Pharmakotherapie bei Haus- und Nutztieren. Stuttgart: Parey; 2006: 63-124.
• 22 Nguyen D, Abdul-Rasool I, Ward D, Hsieh J, Kobayashi D, Hadlock S, Singer F, Bloor B. Ventilatory effects of dexmedetomidine, atipamezole, and isoflurane in dogs. Anesthesiology 1992; 76: 573-579.
• 23 Pagel PS, Proctor LT, Devcic A, Hettrick DA, Kersten JR, Tessmer JP, Farber NE, Schmeling WT, Warltier DC. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs. J Cardiothorac Vasc Anesth 1998; 12: 429-434.
• 24 Rand JS, Reynolds WT, Priest J. Echocardiographic evaluation of the effects of medetomidine and xylazine in dogs. Austral Vet J 1996; 73 (02) 41-44
• 25 Rector E, Kramer S, Kietzmann M, Hart S, Nolte I. Beurteilung der antinozizeptiven Wirkung von systemisch und epidural appliziertem Xylazin in Allgemeinanästhesie mit Isofluran bei Hunden sowie die Auswirkungen der Atipamezolgabe auf die postoperative Analgesie. Berl Münch Tierärztl Wschr 1998; 111: 438-451.
• 26 Redondo JI, Gómez-Villamandoz RJ, Santisteban JM, Domìnguez JM, Ruiz I, Àvila I. Romifidine, medetomidine or xylazin before propofol-halothane-N2O anesthesia in dogs. Can J Vet Res 1999; 63: 31-36
• 27 Schwartz DD, Clark TP. Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep. J Vet Pharmacol Ther 1998; 21: 342-347.
• 28 Van Zwieten PA, Timmermans PB. Central and peripheral α-adrenoceptors. Pharmacological aspects and clinical potentials. Adv Drug Res 1984; 13: 209-254.
• 29 Vickery RG, Sheridan BC, Segal IS, Maze M. Anesthetic and hemodynamic effects of the stereoisomers of medetomidine, an alpha 2-adrenergic agonist, in halothane-anesthetized dogs. Anesth Analg 1988; 67: 611-615.